0001667234-25-000002.txt : 20250815 0001667234-25-000002.hdr.sgml : 20250815 20250815095630 ACCESSION NUMBER: 0001667234-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250815 DATE AS OF CHANGE: 20250815 EFFECTIVENESS DATE: 20250815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Amalgam Rx, Inc. CENTRAL INDEX KEY: 0001667234 ORGANIZATION NAME: EIN: 811299543 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-554907 FILM NUMBER: 251222723 BUSINESS ADDRESS: STREET 1: 1007 N. MARKET STREET STREET 2: SUITE 400 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 983 0001 MAIL ADDRESS: STREET 1: 1007 N. MARKET STREET STREET 2: SUITE 400 CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: iSage Rx, Inc. DATE OF NAME CHANGE: 20160217 D 1 primary_doc.xml X0708 D LIVE 0001667234 Amalgam Rx, Inc. 206 ALAPOCAS DRIVE WILMINGTON DE DELAWARE 19803 302 983 0001 DELAWARE iSage Rx, Inc. Corporation true RYAN A. SYSKO 206 ALAPOCAS DRIVE WILMINGTON DE DELAWARE 19803 Executive Officer Director JEFFREY P. COURTNEY 206 ALAPOCAS DRIVE WILMINGTON DE DELAWARE 19803 Director SONNY VU 206 ALAPOCAS DRIVE WILMINGTON DE DELAWARE 19803 Director Other Health Care Decline to Disclose 06b false 2025-08-08 false true true false 0 ERG SECURITIES (US) LLC 121057 None None 50 WASHINGTON STREET SUITE 921 NORWALK CT CONNECTICUT 06854 NY NEW YORK false 7886530 7886530 0 A portion of the offering amount represents loan proceeds, which are convertible into equity securities of the issuer pursuant to the terms and conditions of a loan and security agreement. false 28 616250 true 0 In connection with the offering, a portion of the sales commission will be paid to the broker in the form of a warrant to purchase preferred stock of the issuer. 0 false Amalgam Rx, Inc. /s/ Ryan A. Sysko Ryan A. Sysko Chief Executive Officer 2025-08-15